BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Tosk Incorporated

Neurodegenerative diseases and cancer. The Company’s AON QTS technology not only targets the neurodegeneration process, which will allow discovered drugs to be applicable to a variety of AON diseases caused by different initial events (e.g., Alzheimer’s, Parkinson’s, multiple sclerosis, etc.), but also optimizes the rational drug design approach by selecting for drugs based on their therapeutic activity.


Contact Details:
2125 Delaware Avenue, Suite B
Santa Cruz
CA
95060
United States of America
Tel:831-426-6838
Fax:831-426-6808
Email:
WWW:

www.tosk.com/




Loading...

Tosk Incorporated Patents:

US Patent No.Title
6855504 In vivo high throughput toxicology screening method
6475798 P element derived vector and methods for its use
6365129 Invivo high throughput toxicology screening method
6316690 Non-mammalian transgenic animal model for cellular proliferative diseases
6291243 P element derived vector and methods for its use

View more Tosk Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 129 times since April 2007, the link to the organisation's website has been followed 44 times

Recent Search Terms used to find this page: www.tosk.com | Tosk Incorporated | .

Search for more companies in Santa Cruz

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Tosk Incorporated

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.